Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Uma Sinha
Age : 64
Public asset : 274,553 USD
Country of residence : Unknown
Linked companies : Eidos Therapeutics, Inc. - BridgeBio Pharma, Inc. - Social Capital Suvretta Holdings Corp. III

Biography of Uma Sinha 
Currently, Uma Sinha occupies the position of Chief Scientific Officer of BridgeBio Pharma, Inc. and Chief Scientific Officer for Eidos Therapeutics, Inc. (a subsidiary of BridgeBio Pharma, Inc.). Dr. Sinha previously held the position of Chief Scientific Officer of Global Blood Therapeutics, Inc., Principal at COR Therapeutics, Inc., Senior Director-Cardiovascular at Millennium Pharmaceuticals, Inc., Principal at Genencor International, Inc. and Vice President & Head-Biology at Portola Pharmaceuticals, Inc. She received a doctorate from the University of Georgia and an undergraduate degree from Presidency College.


Current positions of Uma Sinha 
Holdings of Uma Sinha 
Uma Sinha : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Uma Sinha : Connections 


Latest news about Uma Sinha 
2021Social Capital Suvretta Holdings Corp. III Announces Board Changes
CI
2021Eidos Therapeutics, Inc. Announces Board Changes
CI
2021Insider Sale at Eidos Therapeutics (EIDX) Continues Selling Trend
MT
2021Significant Insider Selling in Shares of Eidos Therapeutics (EIDX) Continues
MT
2020INSIDER TRENDS : Eidos Therapeutics Insider Continues 90-Day Selling Trend
MT
2020INSIDER TRENDS : Eidos Therapeutics Insider Extends 90-Day Selling Trend
MT
2019Eidos Therapeutics, Inc. Uma Sinha as Director, Effective December 11, 2019
CI
More news